Hospital Heliópolis, Brazil.
Braz J Otorhinolaryngol. 2010 Nov-Dec;76(6):700-3. doi: 10.1590/S1808-86942010000600005.
Laryngeal squamous cell carcinoma is very often diagnosed at advanced stages. The time interval between the specialist consultation and the start of treatment may contribute to better outcomes.
the interval assessment between the first specialist evaluation and the treatment of patients with laryngeal squamous cell carcinoma.
longitudinal historical cohort.
272 consecutive patients with laryngeal squamous cell carcinoma seen between January, 1996 and December of 2004. Clinical and epidemiological data were evaluated, as well as their association with the time interval between the first specialist visit and the start of treatment.
the median time between first evaluation and treatment was 49 days. There was no relationship with gender, age, birth place, disease stage or education.
the treatment median delay was 49 days, similar to what has been reported in other studies.
喉鳞状细胞癌通常在晚期诊断。专家咨询与治疗开始之间的时间间隔可能有助于改善预后。
评估喉鳞状细胞癌患者首次专家评估与治疗之间的间隔时间。
纵向历史队列研究。
连续纳入 1996 年 1 月至 2004 年 12 月间的 272 例喉鳞状细胞癌患者。评估了临床和流行病学数据,并将其与首次就诊与治疗开始之间的时间间隔进行了关联分析。
首次评估与治疗之间的中位时间间隔为 49 天。该时间间隔与性别、年龄、出生地、疾病分期或教育程度无关。
治疗中位延迟时间为 49 天,与其他研究报道的结果相似。